APA (7th ed.) Citation

Ennishi, D., Takata, K., Béguelin, W., Duns, G., Mottok, A., Farinha, P., . . . Steidl, C. (2019). Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition. Cancer discovery, 9(4), 546. https://doi.org/10.1158/2159-8290.CD-18-1090

Chicago Style (17th ed.) Citation

Ennishi, Daisuke, et al. "Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition." Cancer Discovery 9, no. 4 (2019): 546. https://doi.org/10.1158/2159-8290.CD-18-1090.

MLA (9th ed.) Citation

Ennishi, Daisuke, et al. "Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition." Cancer Discovery, vol. 9, no. 4, 2019, p. 546, https://doi.org/10.1158/2159-8290.CD-18-1090.